Referred from JSC. With respect to disputes arising from matters delegated or referred to the JSC pursuant to the terms of this Agreement, either Party may, by written notice to the other Party, have such dispute referred to each Party’s Executive Officers for attempted resolution by good faith negotiations within [ * ] after such notice is received. If the Executive Officers of the Parties are not able to resolve a dispute within the [ * ] period described above, then the Executive Officer of Allos or Mundipharma, as the case may be, shall have the unilateral right to cast the deciding vote for the JSC as provided in Section 13.2(a) or 13.2(b). If neither Party has the right to cast the deciding vote for the JSC pursuant to Section 13.2(a) or 13.2(b) (e.g., where Section 13.2(a) or 13.2(b) provides for exceptions to the Executive Officer’s right to make the final decision), then either Party may submit the dispute for resolution pursuant to Section 13.1.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Allos Therapeutics Inc)
Referred from JSC. With respect to disputes arising from matters delegated or referred to the JSC pursuant to the terms of this Agreement, either Party may, by written notice to the other Party, have such dispute referred to each Party’s Executive Officers for attempted resolution by good faith negotiations within [ * [***] after such notice is received. If the Executive Officers of the Parties are not able to resolve a the dispute within the [ * [***] period described above, then the Executive Officer of Allos Licensor or MundipharmaLicensee, as the case may be, shall have the unilateral right to may cast the deciding vote for the JSC as provided in Section 13.2(a) or 13.2(b). If neither Party has the right to cast the deciding vote for the JSC pursuant to Section 13.2(a) or 13.2(b) (e.g., where Section 13.2(a) or 13.2(b) provides for exceptions to the Executive Officer’s right to make the final decision), then either Party may submit the dispute for resolution by arbitration pursuant to Section 13.1.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Windtree Therapeutics Inc /De/)
Referred from JSC. With respect to disputes arising from matters delegated or referred to the JSC pursuant to the terms of this Agreement, either Party may, by written notice to the other Party, have such dispute referred to each Party’s 's Executive Officers for attempted resolution by good faith negotiations within [ * [*] after such notice is received. If the Executive Officers of the Parties are not able to resolve a dispute within the [ * [*] period described above, then the Executive Officer of Allos or Mundipharma, as the case may be, shall have the unilateral right to cast the deciding vote for the JSC as provided in Section 13.2(a) or 13.2(b). If neither Party has the right to cast the deciding vote for the JSC pursuant to Section 13.2(a) or 13.2(b) (e.g., where Section 13.2(a) or 13.2(b) provides for exceptions to the Executive Officer’s 's right to make the final decision), then either Party may submit the dispute for resolution pursuant to Section 13.1.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Allos Therapeutics Inc)
Referred from JSC. With respect to disputes arising from matters delegated or referred to the JSC pursuant to the terms of this Agreement, either Party may, by written notice to the other Party, have such dispute referred to each Party’s Executive Officers for attempted resolution by good faith negotiations within [ * [***] after such notice is received. If the Executive Officers of the Parties are not able to resolve a the dispute within the [ * [***] period described above, then the Executive Officer of Allos Licensor or MundipharmaLicensee, as the case may be, shall have the unilateral right to may cast the deciding vote for the JSC as provided in Section 13.2(a) or 13.2(b). If neither Party has the right to cast the deciding vote for the JSC pursuant to Section 13.2(a) or 13.2(b) (e.g., where Section 13.2(a) or 13.2(b) provides for exceptions to the Executive Officer’s right to make the final decision), then either Party may submit the dispute for resolution pursuant to Section 13.1.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Windtree Therapeutics Inc /De/)